Frank Jaschinski
Inventor
Stats
- 6 US patents issued
- 27 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 6 US Patents Issued
- 27 US Applications Filed
- 149 Total Citation Count
- May 22, 2024 Most Recent Filing
- Dec 11, 2007 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| ISARNA THERAPEUTICS GMBH | 5
1 | 2014
2017 |
| ANTISENSE PHARMA GMBH | 2
2 | 2010
2011 |
| THE GENETICS COMPANY INC. | 1
| 2007
|
Inventor Addresses
| Address | Duration |
|---|---|
| Marburg, DE | Jan 13, 22 - Nov 21, 24 |
| Obertraubling, DE | Jan 03, 12 - Mar 27, 18 |
| Puchheim, DE | Nov 02, 17 - Feb 20, 25 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 14 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 11 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2025/0059,547 | 2025 | NLRP3 oligonucleotide for use in preventing and/or treating an inflammatory disease | 0 |
| 2024/0384,272 | 2024 | ANGPTL4 OLIGONUCLEOTIDES INFLUENCING THE REGULATION OF THE FATTY ACID METABOLISM | 0 |
| 12024708 | 2024 | ANGPTL4 oligonucleotides influencing the regulation of the fatty acid metabolism | 0 |
| 11959083 | 2024 | Immunosuppression-reverting oligonucleotides inhibiting the expression of CD39 | 0 |
| 2024/0076,673 | 2024 | Oligonucleotides reducing the amount of CD73 mRNA and CD73 protein expression | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.